Data / Form D filings / Vascular Perfusion Solutions, Inc.
Vascular Perfusion Solutions, Inc.: Form D filings
Vascular Perfusion Solutions, Inc., a biotechnology company in San Antonio, TX, filed 8 Form D notices with the SEC between 2019 and 2025. The latest, on May 30, 2025, reports $147 million sold of a $343.8 million offering to 21 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 8647 WURZBACH ROAD, SUITE J-200, San Antonio, TX, 78240
- Phone
- (210) 977-0191
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1779735
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 30, 2025 | New notice | $343,766,315 | $147,017,491 | $196,748,824 | 21 | May 16, 2025 | sec.gov |
| Jun 8, 2023 | New notice | $2,500,000 | $500,000 | $2,000,000 | 1 | May 25, 2023 | sec.gov |
| May 20, 2022 | New notice | $5,000,000 | $500,000 | $4,500,000 | 1 | May 17, 2022 | sec.gov |
| Nov 12, 2021 | New notice | $3,000,000 | $850,000 | $2,150,000 | 2 | Oct 29, 2021 | sec.gov |
| Aug 2, 2021 | New notice | $3,000,000 | $1,050,000 | $1,950,000 | 3 | Jul 20, 2021 | sec.gov |
| Aug 26, 2020 | New notice | $2,500,000 | $2,375,000 | $125,000 | 6 | Aug 12, 2020 | sec.gov |
| Oct 22, 2019 | New notice | $1,500,000 | $602,402 | $897,598 | 13 | Oct 11, 2019 | sec.gov |
| Jun 24, 2019 | New notice | $8,000,000 | $2,000,000 | $6,000,000 | 1 | Jun 13, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| C. Thomas Mayes | Executive Officer, Director | |
| Rafael Veraza | Executive Officer, Director | |
| Toni Thomas Haenninen | Executive Officer | |
| Celia Thomas Jairala | Director | |
| Leon Bunegin | Executive Officer, Director | |
| Kristina Thomas Andrijauskaite | Executive Officer |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of May 26, 2025 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Vascular Perfusion Solutions, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.